Steven Lubitz is Director in Translational Medicine at Novartis. OpenAlex indexes 622 publications with 56,352 citations (h-index 102); ClinicalTrials.gov lists 3 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Clinical Cardiac Electrophysiology profiles in the FindMyKOL directory.
Data verified 7 Nov 2026
Overview
Updated 7 Nov 2026
Steven Lubitz, M.D., is Director in Translational Medicine at Novartis. The public record shows 622 publications with 56,352 citations (h-index 102), centered on Genetic Associations and Epidemiology, Atrial Fibrillation Management and Outcomes, Cardiac electrophysiology and arrhythmias. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 2 companies, 2 NIH-funded awards (2013–2021).
- Most recent indexed publication: 2026 · Nature cardiovascular research
- Top research focus: Genetic Associations and Epidemiology
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 7 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. 82 in PubMed. Counts exclude supporting files.
Citations across these publications.
H-index from these publications. i10-index 353.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 7 Nov 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- Screening for Atrial Fibrillation Among Older Patients in Primary Care Clinics
Sponsor: Massachusetts General Hospital
- Automated Physician Notifications to Improve Guideline-Based Anticoagulation in Atrial Fibrillation
Sponsor: Massachusetts General Hospital
Industry payments
Updated 7 Nov 2026
2 companies reported payments to CMS in program years 2021–2022. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year20221 payment
- E.R. Squibb & Sons, L.L.C.Program year20215 payments$31,925openpaymentsdata.cms.gov ↗
- PFIZER INC.Program year20211 payment
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
100%Beta blocker100%Metoprolol Succinate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 7 Nov 2026
2 NIH research awards on record, funded 2013–2021 per NIH RePORTER. The latest:
Congress activity
Updated 7 Nov 2026
51 congress contributions (2020–2026) across AHA, ESC, HRS, ISPOR per OpenAlex. The most recent:
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 7 Nov 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Deep learning-enabled assessment of right ventricular size and function is associated with cardiovascular outcomes.
Nature cardiovascular research
Article2026 - ECG-Based Deep Learning to Predict Incident Atrial Fibrillation Burden.
Journal of the American Heart Association
Article2026 - Rare coding variant architecture and gene discovery from 130,000 sequenced cases of atrial fibrillation.
Research square
Article2026 - Predicting Recurrence and Outcomes After Stressor-Associated Atrial Fibrillation Using ECG-Based Deep Learning.
Journal of the American Heart Association
Article2026 - Artificial Intelligence-Enabled ECG Analysis to Predict Incident Heart Failure.
Circulation. Heart failure
Article2026
Most-cited works
by citation count (OpenAlex)- 01The mutational constraint spectrum quantified from variation in 141,456 humansArticle9,355 citations2020
- 02
- 03Sequencing of 53,831 diverse genomes from the NHLBI TOPMed ProgramArticle2,192 citations2021
- 04
- 05A genomic mutational constraint map using variation in 76,156 human genomesArticle1,691 citations2023
Network
Updated 7 Nov 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 7 Nov 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/steven-lubitz-md
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Steven-Lubitz
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Apple Podcasts
podcasts.apple.com/us/podcast/circulation-march-29-2022-issue/id1108662449
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗ - Apple Podcasts
podcasts.apple.com/us/podcast/circulation-november-8-2022-issue/id1108662449
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗ - Other
advances.massgeneral.org/contributors/contributor.aspx
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →advances.massgeneral.org ↗ - Other
ahajournals.org/do/10.1161/podcast.20230508.341224
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ahajournals.org ↗ - Other
giving.broadinstitute.org/broadignite/team/steven-lubitz
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →giving.broadinstitute.org ↗ - Other
massgeneralbrigham.org/en/doctors/l/steven-lubitz-2997128
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneralbrigham.org ↗ - Other
medscape.com/viewarticle/962224
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medscape.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 7 Nov 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneralbrigham.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneralbrigham.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →advances.massgeneral.org ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →giving.broadinstitute.org ↗
Secondary affiliations
appointments beyond the home institution- Associate Member
Broad Institute of MIT and Harvard
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →giving.broadinstitute.org ↗ - Assistant Professor of Medicine
Harvard Medical School
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →giving.broadinstitute.org ↗ - Cardiologist
Department of Medicine, Massachusetts General Hospital
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →giving.broadinstitute.org ↗ - Physician at Mass General Brigham
Electrophysiology, Boston, MA
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →massgeneralbrigham.org ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ahajournals.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medscape.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Carsten Russ
Novartis
Ver Luanni Feliciano Bilano
Novartis
J E de Vries
Novartis
Ronenn Roubenoff
Novartis
Paul Ridker, MD
Brigham and Women's Hospital
Edward Giovannucci, MD, ScD, MPH
Harvard T.H. Chan School of Public Health
Stephen Chanock, MD
National Cancer Institute (NCI)
Richard Mayeux, MD
Columbia University College of Physicians and Surgeons